March 15, 2024 · Form 4 insider transaction
Singleton Mark Leonard bought 42,202 shares of Bioventus Incorporated at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 7 days after the transaction.
Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock.; The RSUs shall vest on June 15, 2024, subject to the Reporting Person continuing in service through the applicable vesting date.